La Renon Healthcare key facts
- Operator of a healthcare company intended to treat chronic illnesses and diseases.
- La Renon Healthcare’s last known valuation is $1.2B.
- It has raised $116.1M; the latest was Secondary Transaction - Private ($124.5M) in Nov 2025.
- Notable investors include Peak XV Partners, A91 Partners, Siguler Guff, White Oak Capital Management, Avendus Capital — 7 tracked in total.
- Status: Privately Held (backing).
Who backs La Renon Healthcare
7- ·Watch La Renon Healthcare: the Monday email on marks, rounds and moves
La Renon Healthcare funding rounds
No funding rounds for La Renon Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
La Renon Healthcare valuation
La Renon Healthcare's last known valuation is $1.2 billion. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
La Renon Healthcare investors
7 investors are on record for La Renon Healthcare, including Peak XV Partners, A91 Partners, Siguler Guff and White Oak Capital Management.
About La Renon Healthcare
Operator of a healthcare company intended to treat chronic illnesses and diseases. The company operates in chronic segments of nephrology, neurological disorders, critical care, gynecology, ortho, gastroenterology, urology, respiratory and cardio-metabolic diseases, enabling healthcare professionals to treat their patients and improve their lives.
- Sector
- Healthcare
- HQ
- Ahmedabad, India
- Founded
- 2007
- Employees
- 4,000
- Website
- larenon.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
La Renon Healthcare’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.